Pure Global AI
ANVISA registration 10071770877Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 10071770877ABBOTT DIAGNOSTICOS RAPIDOS S.A.ABBOTT DIAGNOSTICS TECHNOLOGIES ASRisk Class II
Verified
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
View exact technical-name matches →
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
NycoCard HbA1c Controle
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
10071770877
Process Number
25351993912201604
CNPJ
50248780000161
Company information
Registration Holder
ABBOTT DIAGNOSTICOS RAPIDOS S.A.
Manufacturer
ABBOTT DIAGNOSTICS TECHNOLOGIES AS
Manufacturing Country
Norway
PT: NORUEGA
Dates and status
Publication Date
Jul 11, 2016
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10071770877 and manufactured by ABBOTT DIAGNOSTICS TECHNOLOGIES AS. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.